Nifty IT Bottoming Out at 23,700? Are You Ready for Short-Term Gains?

Nidhi Thakur

May 25, 2026

Nifty IT Bottoming Out at 23,700? Are You Ready for Short-Term Gains?

TLDR

Nifty IT shows early bottoming and a possible range breakout above 23,700 in the expiry week.
Direct impact: near-term trading opportunities in Surya Roshni and Cholamandalam Investment; pharma stocks face profit-booking risk.
Top priority sector to watch: IT
Action today: look for short-term setups in Surya Roshni and Cholamandalam Investment with strict risk controls

What Happened

Geojit Investments’ Anand James notes early bottoming signs in the Nifty IT index and expects Nifty to attempt a range breakout above 23,700 during the monthly expiry week. He also cautions about near-term profit booking in Pharma stocks, while he highlights bullish technicals on Surya Roshni and Cholamandalam Investment for short-term trading opportunities.

Why This Matters

For retail investors, IT could lead the near-term move if the 23,700 resistance is breached, offering quick trading setups. Pharma’s profit-booking could limit upside in that beta group, underscoring a stock-picking approach within a volatile expiry week. Keeping an eye on Surya Roshni and Cholamandalam Investment may provide more defined risk-reward opportunities in the short term.

Portfolio and Strategy Focus

What This Means For Your Portfolio

If Nifty sustains above 23,700, you could see a short-term lift in IT-focused names and related mid-cap plays. For you, the key is to maintain a balance between tactical bets and core long-term holdings, avoiding over-exposure to whipsaw moves as the expiry week unfolds.

Sectors To Watch - Priority Order

1st Priority: IT - likely driver if 23,700 is surpassed, offering short-term entry points
2nd Priority: Pharma - watch for profit-booking relief rallies but be selective
Avoid Now: Real Estate - not a primary beneficiary of the near-term move

Action Points For Investors

SIP investors: Maintain core allocations; avoid funding high-risk short-term trades—let IT-led rallies develop gradually
Lumpsum investors: Do not rush new money into volatile short-term bets; wait for a clear breakout above 23,700 with favorable risk-reward
Traders: Look for short-term entry signals in Surya Roshni and Cholamandalam Investment; use tight stops and book profits on strength

Swastika Investmart notes that the near-term setup in Nifty IT and select IT names could offer trading opportunities for risk-tolerant investors. A cautious approach with stop losses and defined targets is advised. The market is likely to remain choppy around expiry, making selective short-term bets prudent.

Risks and Cautions

Key Risks To Watch

IT may fail to sustain a breakout above 23,700, leading to a pullback and failed short-term rallies
Pharma stocks could extend profit-booking, denting index-level gains and impacting risk appetite
Expiry week often brings volatility and whipsaws; rapid moves can hit stop losses and rapid profits

Frequently Asked Questions

What does the Nifty 23,700 breakout imply for my portfolio?

If 23,700 is breached with momentum, IT-led moves can create short-term trading opportunities; maintain risk controls and avoid overexposure to volatile names.

Should You Buy Surya Roshni and Cholamandalam Investment now?

Yes, if you have a defined short-term plan; bullish signals suggest upside, but use tight stops and limit position size to manage risk.

Is Pharma profit-booking a risk for my holdings?

Yes, near-term profit booking can cap pharma gains; trim exposure if overextended and focus on stock-specific resilience.

What should I watch during expiry week?

Monitor IT index moves around 23,700, pharma stock reactions, and overall volatility; follow a plan with predefined entries and risk limits.

Conclusion

Expiry week could unlock near-term IT momentum if 23,700 holds; stay selective, manage risk, and focus on short-term setups in Surya Roshni and Cholamandalam Investment. Your next step is to observe the 23,700 level and act only when a clear setup forms.